AHFS Drug Information
ASHP Health-System Pharmacists
Free · In‑App Purchases
Trusted by pharmacists & healthcare pros AHFS DI comprehensive evidence-based source of drug info with therapeutic guidelines & off-label uses.
**14-day free trial**
"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.
AHFS® Drug Information™ - Doody's Core Title - is your comprehensive, interactive treatment and drug therapy solution - complete with therapeutic guidelines and off-label uses.
2020, 2021, 2022, 2023, 2024,2025 Doody's Core Titles List Selection
AHFS Drug Information® 2026 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.
With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients and your practice.
With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients and your practice.
Updates in the new edition:
- Clinical perspective sections that include place of therapy discussions and recommendations from therapeutic guidelines
- Expanded coverage of specialty medications used to treat a variety of complex, chronic conditions that often require special handling and administration and may require careful - oversight to manage severe adverse effects and dosage adjustments
- Contemporary topics such as biosimilars, novel orphan drugs, and updated vaccine guidance based on recommendations from the CDC’s Advisory Committee on Immunization Practices (ACIP) and other authoritative organizations
- Essential drug information content for patient safety including FDA Medwatch alerts, Standardize4Safety concentrations for IV and oral liquid medications, ISMP recommendations, REMS data, BEERS criteria, boxed warnings, and focused updates based on FDA safety findings
- Pharmacogenomic considerations in drug dosing and selection
- Expanded content on new and emerging gene and cellular therapies
- Class-wide revisions to standard and established therapies for common disease states including hypertension and diabetes
- Expanded content on off-label uses, real world data, and long-term clinical data
- New content on new molecular entities (NMEs) and biologic approvals
- New oncology off-label determinations based on reviews by the AHFS Oncology Expert Committee
Content licensed from printed ISBN 10: 1585287776
Content licensed from printed ISBN 13: 9781585287772
SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.
Yearly auto-renewing payments- $99.99
Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable."
Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx
https://www.skyscape.com/index/privacy.aspx
Editor(s): American Society of Health-System Pharmacists, Inc.
Publisher: American Society of Health-System Pharmacists, Inc.
Ratings & Reviews
New 2026 Edition Content Update with
- UI/UX enhancements
- Minor bug fixes
The developer, Skyscape Medpresso Inc, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Used to Track You
The following data may be used to track you across apps and websites owned by other companies:
- Identifiers
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- User Content
- Search History
- Identifiers
- Usage Data
- Diagnostics
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- Skyscape Medpresso Inc
- Size
- 155.2 MB
- Category
- Medical
- Compatibility
Requires iOS 13.0 or later.
- iPhone
Requires iOS 13.0 or later. - iPad
Requires iPadOS 13.0 or later. - iPod touch
Requires iOS 13.0 or later. - Mac
Requires macOS 10.15 or later. - Apple Vision
Requires visionOS 1.0 or later.
- Languages
- English
- Age Rating
16+
- 16+
- Frequent
Medical Treatment information
- In-App Purchases
Yes
- AHFS Drug Information 1/Y sub $99.99
- AHFS Drug Info 1/Y sub offer $79.99
- 25% off for Limited Period $74.99
- 20% off for Limited Period $79.99
- 15% off for Limited Period $84.99
- Copyright
- © 1998-2030 Skyscape Medpresso, Inc